EndoMT: An R Package Resource for Endothelial-Mesenchymal Transition Gene Set Enrichment Analysis
This paper introduces the EndoMT R package, a curated resource of directionally assigned gene sets designed to enable specific and sensitive transcriptomic enrichment analysis of endothelial-mesenchymal transition across diverse experimental models and disease contexts, addressing the limitations of existing general epithelial-mesenchymal transition frameworks.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside the body's vast network of blood vessels, the cells lining the tubes are not static bricks; they are dynamic, living entities capable of changing their very nature. Under normal conditions, these endothelial cells form a smooth, protective barrier that keeps blood flowing and prevents unwanted substances from leaking out. However, when the body faces injury, chronic inflammation, or disease, these cells can undergo a profound transformation known as endothelial-to-mesenchymal transition. In this process, the cells lose their specialized vascular identity and begin to resemble a different type of cell called a mesenchymal cell. These new cells are more mobile, can produce structural materials like collagen, and help repair tissue, but when this change happens in the wrong place or at the wrong time, it contributes to serious conditions like heart disease, lung scarring, and cancer. For decades, scientists studying this shift have had to rely on gene lists designed for a different, though related, process called epithelial-to-mesenchymal transition, which occurs in skin and organ linings. This lack of a specific tool meant that researchers were often trying to fit a square peg into a round hole, potentially missing the unique molecular signals that drive blood vessel cells to change.
To solve this problem, a team of researchers has created a dedicated digital toolkit specifically for tracking the genetic changes that occur when blood vessel cells transform. They began by combing through hundreds of scientific studies to build a custom list of genes that act as markers for this specific transition. They organized these genes into two distinct groups: those that turn on as the cells begin to change, and those that turn off as the cells lose their original identity. Crucially, they designed this list to capture the early, partial stages of the transformation, recognizing that cells often exist in a fluid, transitional state before fully becoming a different cell type. The team then packaged this collection of genes into a free software tool that other scientists can use to analyze their own data. By testing this tool against existing datasets from laboratory experiments and human tissue samples, they demonstrated that it could accurately detect the genetic signature of this transition, distinguishing it from other biological processes and identifying subtle changes that broader, less specific tools had missed.
The researchers tested their new resource on several different scenarios to see if it worked as intended. First, they looked at data from human blood vessel cells grown in a lab dish and treated with specific inflammatory signals known to trigger this transformation. When they applied their new gene list, the software clearly identified the cells as having switched on the genes associated with the change and switched off the genes associated with their original state. This confirmed that the tool could spot the transition when it was happening in a controlled setting. But the real power of the new list became apparent when they looked at cells treated with only one of the signals instead of a combination. In these cases, the cells had not fully transformed, yet the new tool still detected a partial shift in their genetic activity. This suggests that the resource is sensitive enough to catch the early warning signs of the process, even before the cells have completely changed their appearance or function.
The team also explored how the timing and dosage of the signals affected the results. In one experiment, cells were exposed to a high dose of a growth factor for a short period. Surprisingly, the new tool showed that these cells did not activate the transformation genes; instead, the genes associated with the change were actually suppressed. This finding highlights that the process is not a simple on-off switch but a complex response that depends heavily on how long and how strongly the cells are stimulated. The researchers then took their tool into more complex environments, analyzing data from single cells within human tumors. They successfully used the gene list to tell the difference between the blood vessel cells and the cancer-associated fibroblasts, which are the cells that support tumor growth. This ability to distinguish between these two cell types in a messy, real-world tissue sample proves that the tool can be used to study the transition in human disease, not just in clean laboratory dishes.
By providing a resource that is tailored specifically to the biology of blood vessel cells, this work offers a clearer window into a process that is central to many human diseases. The researchers emphasize that their list is designed to be flexible, allowing scientists to look at the big picture of the transformation or to zoom in on specific subgroups of genes to understand the finer details. Because the tool is open and accessible, it allows the broader scientific community to re-examine their own data with a sharper focus, potentially uncovering new insights into how vascular diseases develop and how they might be treated. The study does not claim to have solved the mystery of how these cells change, but it provides a much more precise map for the journey, ensuring that future research can navigate the complex landscape of cell transformation with greater accuracy and confidence.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.